This paper is part of the Clinical Trial Endpoints for Dialysis Vascular Access Project of the
American Society of Nephrology Kidney Health Initiative. The purpose of this project is to …

When the evidence of literature is weak, conflicting, or contradictory, consensus for the
parameter is reached by a minimum of 12 Standards of Practice Committee members using …

Rationale & Objective Previous studies have illustrated the potential superiority of drug-
coated balloons (DCBs) in maintaining patency after initial angioplasty for arteriovenous …

With the increasing prevalence of end-stage renal disease, there is a growing need for
hemodialysis. Arteriovenous fistulae (AVF) are the preferred type of vascular access for …

Background: Endovascular treatment of autogenous arteriovenous haemodialysis fistula
stenosis has high reintervention rates. We investigate the effect of drug-eluting balloons in …

Background Native or prosthetic arteriovenous (AV) fistulas are preferred for permanent
haemodialysis (HD) access. These are marked with circuit steno-occlusive disease leading …

Hemodialysis vascular accesses are prone to recurrent stenosis and thrombosis after
endovascular interventions. In vitro data suggest that indoxyl sulfate, a protein-bound uremic …

Objective: Percutaneous transluminal balloon angioplasty (PTA) is recommended as the first
choice to treat stenosis of Brescia-Cimino arteriovenous fistulas (BC AVFs). The ability to …

Purpose Patency after percutaneous transluminal angioplasty of native hemodialysis
arteriovenous fistulae (AVFs) is highly variable. This study aimed to identify predictors of …

Background The objective of this study was to assess postintervention patency and analyze
the predictive factors associated with early and late restenosis after intervention in …